Renal Cancer
Economic burden of renal cell carcinoma in the US: Part II - an updated analysis - Abstract
April 8, 2011
Pazopanib: The newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma - Abstract
April 8, 2011